JMJD2A Antibodies

Santa Cruz Biotechnology delivers a wide array of JMJD2A monoclonal antibodies for various research applications. JMJD2A monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). JMJD2A, a member of the Jumonji C domain-containing family of proteins, functions in the regulation of gene expression through histone demethylase activity. JMJD2A participates in multiple cellular processes, including cell differentiation, proliferation, and response to stress. Understanding JMJD2A activity provides insights into epigenetic regulation in health and disease. Research focusing on JMJD2A continues to reveal significant implications in cancer biology and other pathological conditions. Investigating JMJD2A expression patterns helps scientists uncover new therapeutic targets and treatment strategies. JMJD2A research advances our understanding of cellular mechanisms and disease progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific discoveries and medical breakthroughs.